Consultative Hemostasis and Thrombosis

<p>Kitchens: CONSULTATIVE HEMOSTASIS & THROMBOSIS</p> <p>TOC</p> <p>PART 1: Hemorrhagic Processes</p> <p>1. Consultative Process</p> <p>2. An Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing</p> <p>3. Hemophilia A and B</p> <p>4. Less Common Congenital Disorders of Hemostasis</p> <p>5. Acquired Coagulation Disorders Due to Inhibitors</p> <p>6. von Willebrand Disease</p> <p>7. General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors</p> <p>8. Primary Immune Thrombocytopenia</p> <p>9. Congenital and Acquired Disorders of Platelet Function and Number</p> <p>10. Purpura and Other Hematovascular Disorders</p> <p>11. HHT</p> <p>12. Disseminated Intravascular Coagulation </p> <p>13. The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation</p> <p>PART 2: Thrombotic Processes</p> <p>14. Thrombophilia: Clinical and Laboratory Assessment and Management</p> <p>15. Pediatric Aspects of Thrombophilia</p> <p>16. Deep Vein Thrombosis, Pulmonary Embolism and Primary Pulmonary Hypertension</p> <p>17. Venous Thromboses at Unusual Sites</p> <p>18. The Post Thrombotic Syndrome</p> <p>19. Thrombocytosis: Essential Thrombocytemia and Reactive Causes</p> <p>20. Antiphospholipid Syndrome</p> <p>21. Antiplatelet Treatment in Cardiovascular Medicine</p> <p>22. Non-Arteriosclerotic Arterial Occlusive Disease</p> <p>23. Thrombosis and Cancer</p> <p>24. Thrombotic Thrombocytopenic Purpura</p> <p>25. Hemostatic Disorders of Complement Activation (PNH and aHUS) - New Chapter</p> <p>26. Heparin-Induced Thrombocytopenia</p> <p>PART 3: Therapeutic Agents</p> <p>27. Antithrombotic Agents</p> <p>28. Blood Component and Pharmacological Agents</p> <p>29. Therapeutic Apheresis – Applications for Hemorrhagic & Thrombotic Disorders </p> <p>30. Vena Caval Filters</p> <p>PART 4: Issues Specific to Women </p> <p>31. Thrombotic Risk of Contraceptives and other Hormnal Therapies</p> <p>32. Bleeding and the Management of Hemorrhagic Disorders in Pregnancy</p> <p>33. Thrombophilia in Pregnancy</p> <p>PART 5: Special Issues</p> <p>34. Surgery and Hemostasis</p> <p>35. Anticoagulation in the Perioperative Period</p> <p>36. Understanding and Managing the Coagulopathy of Liver Disease</p> <p>37. Outpatient Anticoagulant Therapy38. Hematologic Interventions for Acute Central Nervous System Disease</p> <p>39. Pending: Atrial Septal Abnormalties and Cryptogenic Stroke</p> <p>40. Hemorrhage Control and Thrombosis Following Severe Injury</p> <p>41. Hemostatic Aspects of Sickle Cell Disease</p>